Sort   by:  
 Page size 
UnknownThe combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma.
Not available
S-EPMC9365737 | biostudies-literature
UnknownEGR2 is a hub-gene in myocardial infarction and aggravates inflammation and apoptosis in hypoxia-induced cardiomyocytes.
Not available
S-EPMC9377070 | biostudies-literature
UnknownBifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial.
Not available
S-EPMC9594927 | biostudies-literature
UnknownEpigenetic therapy inhibits metastases by disrupting premetastatic niches.
Not available
S-EPMC8765085 | biostudies-literature
Sort   by:  
 Page size